Trimebutine (Maleate)

Trimebutine (Maleate) is used as an antispasmodic.

Brands

DEBRIDAT DEBRIDAT DEBRIDAT DEBRIDAT PROCTOLOG PROCTOLOG MEBUTINE TRIBUTINE TRIBUTINE

Adult Dose

Dose: 100 to 200 mg
Single Dose: 150 (150)
Frequency: 12 hourly
Route: PO
Instructions:

Neonatal

Paedriatic

Characteristics

belongs to Aminobenzoate. It belongs to Alpha adrenergic agonist pharmacological group on the basis of mechanism of action and also classified in Gastrointestinal Anticholinergics/Antispasmodics and Antispasmodic Agent pharmacological group.The Molecular Weight of Trimebutine (Maleate) is 503.50.

Contraindications

Trimebutine (Maleate)

Effects

No data regarding the side effects produced by Trimebutine (Maleate) is available

Indications

Trimebutine (Maleate) is primarily indicated in conditions like Abdominal pain, Constipation, Diarrhoea, Digestive disorder, Flatulence, Irritable bowel syndrome, Spasm, and can also be given in adjunctive therapy as an alternative drug of choice in Haemorrhoids, Hemorrhoids.

Interactions

No data regarding the interactions of Trimebutine (Maleate) was found.

Interfrence

Risks

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Storage

Warnings

No data regarding the Warnings/Precuations of Trimebutine (Maleate) is available.

Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.